Showing results (111-120 of 195) with videos related to

Sort By:
Pageof 20
Endocrinology|February 2, 1999
Effects of pro- and antioxidative compounds on renal production of erythropoietinI Neumcke, B Schneider, J Fandrey, et al.
Neuroscience Letters|April 25, 1997
Suppression of the oxidative burst in murine microglia by nitric oxideI Kiprianova, S Schwab, J Fandrey, et al.
FEBS Letters|January 1, 1999
The influence of phenobarbital on cytochromes and reactive oxygen species in erythropoietin producing HepG2 cellsW Ehleben, T Porwol, J Fandrey, et al.
FEBS Letters|July 11, 1994
Effects of cobalt on haem proteins of erythropoietin-producing HepG2 cells in multicellular spheroid cultureA Görlach, J Fandrey, G Holtermann, et al.
Mucosal Immunology|July 30, 2015
Hypoxia-inducible factor 1 in dendritic cells is crucial for the activation of protective regulatory T cells in murine colitisK Flück, G Breves, J Fandrey, et al.
International Journal of Oncology|May 3, 2011
Serum vascular endothelial growth factor (VEGF), a prognostic indicator in sarcoma and carcinoma patientsF Heits, D Katschinski, G Wiedemann, et al.
British Journal of Cancer|March 8, 2012
Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancerM Aapro, W Jelkmann, S N Constantinescu, et al.
European Journal of Haematology|September 1, 1989
Erythropoietin/haemoglobin relationship in leukaemia and ulcerative colitisH Johannsen, W Jelkmann, G Wiedemann, et al.
Endocrinology|February 1, 1986
Erythropoietin production by fetal mouse liver cells in response to hypoxia and adenylate cyclase stimulationA Kurtz, W Jelkmann, A Pfuhl, et al.
Human Reproduction (Oxford, England)|March 25, 1998
Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndromeM Ludwig, O Bauer, A Lopens, et al.
Pageof 20